ARCHIVES

ODAC Advice Poses Challenge to FDA: Would Iressa Approval Erode Standards?

This article is from The Cancer Letter archive.

Vol. 28 No. 41 | November 8, 2002

Download PDF Visit The Full Archive

Related Articles

NCI Raises R01 Payline To 16th Percentile FY09. Coalition Formed To Advocate For Medical Innovation

March 27, 2009

In Brief: Anti-Smoking Resolution Lost In White House; Pay Bill Defeat Leaves 73 At The Top In NCI

March 22, 1974

Greenwald Lists Items Missing Because Not Enough Money Available

November 25, 1988

Emory Cancer Experiment Launched Into Space

January 17, 2003

Seffrin; First Year ACS Shows “Simple Problems Aren’t”

August 6, 1993

Proposed HHS Conflict of Interest Rules May Require More Disclosure by Researchers

May 15, 2009